The information published on Osimert.com is provided for general educational and pharmaceutical-information purposes.
It is not individualized medical advice, diagnosis or treatment guidance.
Prescription medicines require professional supervision
Osimertinib is a prescription cancer medicine. Decisions about whether it is appropriate, how it should be used, whether treatment should be modified and how adverse reactions should be managed require qualified healthcare-professional assessment.
No doctor-patient relationship
Reading information on this website does not create a doctor-patient, pharmacist-patient or other healthcare-provider relationship.
No individualized recommendations
The website does not determine:
- Whether a particular patient should receive osimertinib
- Whether a patient should start or stop treatment
- Whether a dose should be changed
- Whether a patient should combine medicines
- Whether an adverse reaction is safe to manage at home
Regulatory information
Drug approvals, indications, dosage requirements and warnings can vary between countries and may change as new evidence becomes available.
Emergency symptoms
Serious symptoms require appropriate medical attention. Examples include severe breathing difficulty, fainting, severe chest symptoms, extensive blistering or peeling skin, severe eye symptoms or other potentially life-threatening changes.
Accuracy and updates
Reasonable efforts are made to use reliable sources, but no website should be considered a substitute for the current official product information.
Commercial information
Product availability, ordering arrangements, prices, payment methods and delivery policies should be independently confirmed with the relevant authorized supplier.
Final authority
For prescribing decisions, the applicable official regulatory label and qualified healthcare professional should be treated as authoritative.